Defunct Company
Total Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
912
NCT03069144
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Jan 6, 2012
Completion: May 28, 2012
NCT03059693
Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis
Start: Feb 29, 2016
Completion: Jul 24, 2016
NCT03848806
Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
Phase: Phase 2
Completion: Sep 5, 2016
NCT03406117
A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests
Phase: Phase 4
Start: Apr 1, 2016
Completion: Jul 21, 2016
NCT03089229
A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis
Start: Mar 26, 2017
Completion: Jul 31, 2017
NCT06940674
Adjunctive Cannabidiol for Recovery From Opioid Study
Phase: Phase 3
Role: Collaborator
Start: Jun 13, 2025
Completion: Aug 15, 2027